Caldolor Injection
NDC 66220-284
Product Information
Caldolor (ibuprofen) is a NDA-approved product labeled by Cumberland Pharmaceuticals Inc.. Ibuprofen is used to help relieve mild to moderate pain. It is supplied as a injection for intravenous administration. This product entry covers the primary NDC 66220-284 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 66220-284?
What are the uses of this product?
What are Active Ingredients of this product?
- IBUPROFEN 800 mg/200mL - A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- IBUPROFEN (UNII: WK2XYI10QM)
- IBUPROFEN (UNII: WK2XYI10QM) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- ARGININE (UNII: 94ZLA3W45F)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- NITROGEN (UNII: N762921K75)
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2178273 - ibuprofen 800 MG in 200 ML Injection
- RxCUI: 2178273 - 200 ML ibuprofen 4 MG/ML Injection
- RxCUI: 2178273 - ibuprofen 800 MG per 200 ML Injection
- RxCUI: 2178275 - Caldolor 800 MG in 200 ML Injection
- RxCUI: 2178275 - 200 ML ibuprofen 4 MG/ML Injection [Caldolor]
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.